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ABSTRACT 
 
This short review summarizes recent studies on placenta-preeclampsia in the mother and/or 
intrauterine growth restriction in the child. The ideas raised here are framed within a paradigm that 
favors the opening of new research lines in these themes and are focused on the outlining of early 
investigation and/or an adequate treatment for mothers who develop the pathology. Thus, this 
review focuses on those studies that categorize PE in the group of pathologies defined as 
"conformational diseases", as a consequence of the misfolding of proteins due to endoplasmic 
reticulum ER stress. In this particular case, the ER stress that develops in the syncytiotrophoblast 
because of the oxidative stress caused in the placenta by the hypoxia that occurs as a consequence 
of the failure in the remodeling of endometrial arteries. This leads to an increased 
syncytiotrophoblast apoptosis with detachment of misfolded proteins into the maternal circulation, 
which in turn would be primarily responsible for the signs of preeclampsia in the mother: proteinuria, 
edema, and hypertension.  The review also analyzes the preeclampsia-prions-placenta relationship, 
since the normal cell-surface protein PrPc is normally present in the plasma membrane of 
syncytiotrophoblast, but appears to be increased in cases of preeclampsia. However, although 
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neurodegenerative disorders resulting from conformational changes in the prion protein from its 
normal cellular form, PrPc, to the infectious scrapie isoform, PrPSc are well known, limited 
information is available on Pr Pc and PrPSc in the ST, hence review on these proteins gains more 
attention in normal and pathological placenta. 
 
 
Keywords: Preeclampsia; placenta; amyloidosis; prion PrPC; trophoblast; cytotrophoblast; 
syncytiotrophoblast. 
 
1. PLACENTA AND PREECLAMPSIA 
 
The passage of nutrients from the maternal blood 
to the fetus is mediated by the placenta, so the 
normal fetal metabolism and growth require of an 
adequate exchange across this organ [1]. The 
trophoblast is the epithelium that covers the 
placental fetal villous tree and during 
development differentiates into two layers: the 
syncytiotrophoblast (ST) and the cytotrophoblast 
(CT). The former is externally located and 
contains many nuclei and a continuous 
cytoplasm, forming a syncytium. The latter 
consists of a monolayer of ovoid cells 
immediately underlying the ST. Both structures 
contribute to the formation of the villi and 
ultimately the placenta. Villous CT fuse in order 
to form the ST layer that contributes to the 
metabolic exchange of gas and nutrients, as well 
as to the process of waste elimination [2,3]. 
Apoptosis of the trophoblast has been observed 
to naturally occur in placentas of normal human 
pregnancies but, as expected, placentas from 
women with preeclampsia (PE) or intrauterine 
growth retardation (IUGR) show enhanced 
apoptosis when compared with placentas from 
normal pregnancies [4]. 
 
PE is a systemic pregnancy syndrome that 
affects about 3-5% of all pregnancies [5]. This 
pathology is an important contributor to maternal 
and perinatal morbidity and mortality worldwide. 
Because there is no cure other than delivery, PE 
is the leading cause of iatrogenic preterm birth. 
Despite to be of unknown etiology, it is currently 
accepted that this pathology originates in the 
placenta [6] due to the fact that the maternal 
symptoms (high blood pressure and proteinuria) 
disappear once the organ has been expelled 
after delivery [7,8]. 
 
2. OXIDATIVE STRESS 
 
To date, PE has been related to the process of 
hypoxia due to ischemia/reperfusion experienced 
by the placenta as a consequence of extravillous 
trophoblast failure in the process of endometrial 
spiral arteries remodeling. The involvement of 
oxidative stress (OS) in the early placental 
hypoxia development has been previously 
proposed in the mechanism of the syndrome 
[1,5,8,9]. Due to the fact that the human fetal-
placental vasculature lacks autonomic 
innervation, it is reasonable to assume that 
autocrine and/or paracrine agents such as the 
NO radical may play an important role in the 
regulation of fetal-placental blood flows [9]. 
 
On the other hand, OS constitutes a unifying 
mechanism of injury involved in many types of 
disease. It occurs when there is an imbalance 
between the production of ROS and the ability of 
the biological system to readily detoxify these 
reactive oxidative species (ROS) or the tissues 
cannot easily repair the resulting damage [10]. In 
PE it has been shown that enhanced ROS 
generation leads to a decrease in the NO 
bioavailability [11]. Increased generation of 
superoxide anion by the placenta leads to 
increased peroxynitrite production, resulting in 
further oxidative stress and endothelial 
dysfunction in PE patients [8]. Additionally, it has 
been well established that NO disrupts the 
mitochondrial respiratory chain in a dose 
dependent manner, causing changes in the 
mitochondrial Ca2+ flux that induce ER Stress in 
pluripotent stem cells [12]. Taking all of these 
evidences into account, it is plausible to assume 
that OS developed in the placenta by the 
exaggerated generation of ROS would trigger ER 
stress in the organ, which in turn will increase the 
apoptosis of the ST. 
 
3. PLACENTAL ER STRESS AND 
AMYLOIDOSIS 
 
In the last few years, a number of studies 
suggesting that PE could be triggered by 
disorders in the folding of proteins in the ER of 
the ST, which results in amyloid deposits in this 
organelle [13-16] have been published.  In light 
of this evidence, the accumulation of misfolded 
protein in the ER lumen has been defined as ‘ER 
Stress’ [17-20]. 
 
In addition, ER stress has recently been 
identified as a major regulator of cell 
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homeostasis through its involvement in post-
translational protein modification and folding, as 
well as its capacity to activate the unfolded 
protein response (UPR) which aims to restore 
the homeostatic balance within the ER [21]. If 
this cannot be achieved, the cell apoptotic 
machinery becomes consequently activated. The 
initial intent of the UPR is to adapt the cell to the 
changing environment, and reestablish normal 
ER function. These adaptive mechanisms involve 
transcriptional programs that induce expression 
of genes that enhance the protein folding 
capacity of the ER, and promote ER-associated 
protein degradation to remove misfolded proteins 
[17]. Persistent protein misfolding initiates 
apoptotic cascades [21] that are known to play 
fundamental roles in the pathogenesis of multiple 
human diseases, including diabetes, 
atherosclerosis, PE and neurodegenerative 
diseases [14-16,22,23], all of which have been 
defined as “conformational diseases”. 
 
The ER stress due to misfolded proteins in the 
ST increases placental apoptosis in this epithelial 
layer [16,18]. Moreover, due to the fact that the 
ST establishes direct contact with the maternal 
blood, the apoptotic process produces 
detachment of the syncytial infolding proteins, 
accumulated due to ER stress, to the maternal 
blood. Consequently, these particles will be 
mainly responsible for the development of PE 
symptoms in the mother. Recently, we found that 
the Amyloid A (AA) was present in the ST of PE 
and IURG placentas, and that the degree of 
apoptosis of the CT regulates the amyloidosis 
destiny of the AA in the ST [16]. In brief, in PE 
cases the misfolded proteins are expelled to the 
maternal blood. On the contrary, in the IURG 
cases they are deposited on the basal lamina of 
the trophoblast, without being expelled from the 
placenta, but also altering the mother/fetus 
metabolic exchange, thus producing IUGR. 
Moreover, Hitomi et al. [24] suggested that 
activation of ER-resident caspase-12 indirectly 
activates cytoplasmic caspase-3 and might be 
important in ER stress-induced neuronal 
apoptosis as a consequence of the presence of 
misfolded proteins. This is in agreement with our 
placental study [16] which showed the presence 
of active caspase 3 in the CT of PE placentas 
with AA amyloidoses, but not in the CT of normal 
placentas. 
 
It has also been reported that caspase-12-
deficient mouse cortical neurons were defective 
in apoptosis induced by amyloid-beta protein, but 
not by trophic factor deprivation [25]. Thus, 
caspase-12 mediates an ER-specific apoptosis 
pathway and may contribute to amyloid-beta 
neurotoxicity. This idea is in concordance with Fu 
et al. [26] who found significantly higher caspase 
12 activity in placentas of early or late severe PE. 
It is important to note that ER stress apoptosis 
can be induced by other various pathological 
conditions that alter the ER function. In the same 
line of evidence, Wang et al. [27] experimentally 
induced ER stress and apoptosis in placentas of 
pregnant rats exposed to lead, which was 
accompanied by an increase in the caspase-12 
m RNA expression, and Xu et al. [28] found an 
increase in the early expression of ER stress 
markers, followed by increased activity of 
caspase 12 in placental trophoblast exposed in 
vivo and in vitro to T. gondii, followed by an 
increased apoptosis of the exposed trophoblasts. 
Similar results were found by Wang et al. [29] in 
neural stem cells exposed to this parasite. It 
should be emphasized that in the last three 
investigations no studies were carried out in 
order to evaluate the presence of misfolding 
proteins in the placentas, which would have 
allowed amyloidosis to be discarded. It is also 
important to note that in a case control study 
where pregnant women suspected of T. gondii 
infection were treated with spiramycin, a 
macrolide antibiotic administered before 18 
weeks of pregnancy in order to reduce the rate of 
transmission of the parasite to the fetus, reported 
a reduced incidence of pregnancy-induced 
hypertension [30]. On the basis of these results, 
the association of T. gondii infection with 
hypertension disease during pregnancy needs to 
be further investigated. 
 
In another line of evidence, transthyretin (TTR) is 
a homotetrameric serum and cerebrospinal fluid 
protein. The TTR dissociation forms monomer 
misfolding, a variant of TTR that results in familial 
amyloid polyneuropathy, familial amyloid 
cardiomyopathy, or familial central nervous 
system amyloidosis [31]. TTR is also a carrier 
protein for thyroxin and retinol binding protein, 
which are secreted by trophoblast. McKinnon et 
al. [32] and Mortimer et al. [33] have reported 
that human placenta secretes TTR into the 
maternal and fetal circulations and that placental 
TTR secreted into the maternal placental 
circulation can be taken up by the trophoblasts 
and translocated to the fetal circulation, thus 
conforming a TTR shuttle system. This may have 
important implications for maternal-fetal transfer 
of thyroid hormones, retinol/retinol binding 
protein and xenobiotics, all of which bind to TTR. 
Additionally, Fruscalzo et al. [34] demonstrated 
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that TTR is dysregulated in cases of IUGR and 
severe early onset PE, and Kalkunte, et al. [13] 
showed the presence of amyloid aggregates of 
TTR in PE placentas, as well as in the serum of 
these patients. 
 
Taken together, all these evidences allow us to 
postulate that by effect of the OS the placenta 
develops ER stress in the ST and CT, which 
leads to the accumulation of misfolded proteins 
and, if the quantity greatly increases, this will 
finally activate the UPR with the consequent 
increase of ST apoptosis and therefore the 
release of the misfolded proteins into the 
maternal blood, which in turn will trigger the 
symptoms of PE in the mother. 
 
4. NORMAL CELLULAR PRION PROTEIN 
FORM IN PLACENTA 
 
The study of this prion protein was initiated due 
to its involvement in a number of related 
neurodegenerative disorders seen in various 
species (bovine spongiform encephalopathy in 
cattle, scrapie in sheep and Creutzfeldt–Jakob 
disease in humans). The name ‘prion’ (for 
Proteinaceous Infectious) was coined as the 
infectious agent of these diseases was found to 
be significantly constituted by proteins [35]. A 
protein with identical sequence was found to be 
expressed in significant quantities in the brains of 
non-diseased animals. Hence, a consensus was 
reached that the protein existed in two distinct 
forms: the normal cellular prion protein form 
(PrPc) and the diseased or scrapie form (PrPSc). 
However, recent evidence suggests that the 
scrapie form of the protein may be sufficient by 
itself for transmission of the disease [36]. 
Transmissible spongiform encephalopathies 
(TSE) or prion diseases are characterized by the 
deposition of PrPc in the structurally altered 
PrPsc form.  While PrPc configuration is primarily 
α-helix and susceptible to proteolysis, PrPSc 
instead forms fibrillar aggregates containing a 
high percentage of β-sheet and is rather resistant 
to proteolytic digestion [37]. TSE condition is 
accompanied by physiological symptoms similar 
to those of aging which, in turn, have been 
shown to be affected by divalent metal ions 
[38,39]. Over the past three decades, the role of 
metal ions in TSE has attracted considerable 
attention particularly since 1970s, when Cu2+ 
chelator-induced histopathological changes were 
documented to be similar to scrapie [40]. Metal 
ions have been implicated as potential 
pathogenic candidates owing to their properties 
of being free-radical generators and their 
association with metalloenzymes such as 
superoxide dismutases (SODs), redox enzymes 
important for cellular resistance to oxidative 
stress [41]. Pathological features of TSE 
resemble neuronal and brain tissue loss as is 
observed in the case of free radical-mediated 
oxidative damage [42].  
 
On the other hand, PrPc, a copper-binding 
glycophosphatidylinositol-anchored protein 
whose function is to protect the cells against 
oxidative stress and to prevent the apoptosis it is 
expressed in the plasma membrane of neural 
and not neural tissues [43-46]. A number of roles 
in neuroprotection, cellular homeostasis, 
response to oxidative stress, cell proliferation 
and differentiation, synaptic function and signal 
transduction have been proposed for PrPc 
[43,47]. Additionally, it has been shown that the 
abnormal isoform of PrPSc is able to induce 
further PrPc → PrPSc transition, accumulating in 
infected brains and forming amyloid plaques 
involved in prion diseases such as TSE, a 
disease with neuronal death and gliosis, 
producing extensive and sponge-like tissue 
vacuolization [37,38,48]. Additionally, Hetz et al. 
[49] demonstrate that prion diseases 
characterized by accumulation of the misfolded 
protease-resistant form of the prion (PrPSc) 
produce neuronal death by apoptosis that also 
correlated with caspase 12 activation in neural 
mouse cells treated with PrPSc. Furthermore, it 
has also been reported that the hypoxia-inducible 
factor-1 alpha (HIF-1α), which appears to be a 
master regulator of the cellular response to 
hypoxia [50], regulates PrPc expression in order 
to protect against neuron cell damage [51]. In 
correlation with this, a variety of studies have 
shown that women with PE are characterized by 
persistently elevated placental HIF-1α levels that 
promote enhanced transcription of genes 
encoding the soluble antiangiogenic protein fms-
like tyrosine kinase-1 (sFlt-1), the soluble 
antiagiogenic factor endoglin (sEngs) and 
endothelin-1 (ET-1), a powerful vasoconstrictor 
known to contribute to this pregnancy pathology 
[52-56]. Moreover, Donadio et al. [57] and Alfaidy 
et al. [58] reported that PrPc is highly expressed 
in the human placenta, especially in CT and ST, 
and Hwang et al. [59] found that the 
immunohistochemical expression of PrPc was 
increased in CT and ST of PE placentas versus 
those from the controls.  Additionally, Brown et 
al. [60] and Brown and Besinger [61] 
demonstrated in mouse neurons that PrPc may 
directly or indirectly regulate the activity of Cu/Zn 
superoxide dismutase (Cu/Zn SOD). In this 
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context, our group found a decreased activity of 
Cu/Zn SOD in PE placentas versus normal 
placentas with an increased of F2-isoprostanes, 
a lipid peroxidation indicator [62]. Furtheremore, 
Klamt et al. [48] found a decreased activity of 
SOD in liver, heart, hippocampus and cerebellus 
in PrPc knockout and wild-type mice and an 
oxidative damage in proteins and lipids.  In 
addition, Anantharam et al. [47] found that PrPc 
plays a proapoptotic role during ER stress.  
 
On the bases of the above arguments, we 
consider of the essential interest to carry out new 
research aimed at investigating the possible 
presence of PrPsc in ST and CT in cases of 
severe PE and eclampsia.  This, due to the fact 
that poorly folded proteins form amyloid 
precipitates, and because in PE, our group found 
a decrease in the activity of the antioxidant 
enzyme SOD [62] which is regulated by PrPc 
[61]. It is noteworthy that in the cases of pregnant 
mothers who develop eclampsia, the maximum 
expression of PE, the maternal endothelial 
damage can lead to severe intracranial 
(intracerebral and subarachnoid) hemorrhage 
and cerebral venous thrombosis, preceded by 
visual hallucinations and the final appearance of 
convulsions and coma [63]. 
 
We would like to hypothetically propose that the 
presence of PrPSc in the ST and CT of the 
placenta of these mothers could be related to the 
increase of apoptosis in these cells and also with 
the significant maternal endothelial damage 
observed, since the release of PrPSc into the 
maternal blood would allow these misfolded 
proteins reach the blood-brain barrier. Therefore, 
it would be essential to perform brain biopsies of 
women who have died from eclampsia for the 
determination of amyloidosis and/or PrPSc [64]. 
Finally, it is important to note that in sheep 
placentas exposed naturally to PrPSc, the 
presence of PrPSc in the trophoblast has been 
shown by immunohistochemistry and/or ELISA 
essays [65]. 
 
5. CONCLUSIONS 
 
This review concludes that the latest studies 
show evidence of a relationship between the 
presence of placental amyloidosis and PE. The 
amyloidosis condition may be either due to an 
increased ER stress in the trophoblast, or to an 
increase in the caspase 12 activity in the ER of 
these cells and an increase in caspase 3 activity 
in the CT, whose cells define the fate of the 
misfolding proteins in the ST. 
This review also emphasize the presence of the 
normal prion PrPc in the plasma membrane of 
the CT and ST, whose presence has been 
noticed to increase in cases of PE. However, it is 
important to analyze what type of response will 
occur if in vitro BeWo cells are subjected to 
exposure of the prion isoform PrPSc. 
 
6. PROJECTIONS 
 
Future studies are required in order to elucidate 
the functional role of increased amyloidosis and 
PrPc in the placenta of PE pregnancy, and to 
establish whether the determinations of amyloids 
[14] or PrPc [59] in urine or serum of this women 
could be used to prevent or predict this 
pregnancy pathology.  
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